Files
Abstract
Peste des petits ruminants (PPR) is one of the most important viral diseases of goats and sheep. The disease is endemic in several parts of Asia and Africa and causes huge losses. A PPR vaccine has been developed in India which is effective and provides lifetime immunity to the target species. The vaccine is the only way to combat the disease by controlling and subsequently eradicating it. This paper has assessed the probable economic impact of this vaccine. The probable economic losses due to mortality of adult population alone because of this disease have been estimated at Rs 169.42 million.The costs of PPR vaccine production at commercial scale have also been worked out. Manufacturing costs of a single dose is reported to be Re 0.58 only. The benefit-cost ratio has been estimated to be 2.25. The vaccine if used in an effective manner, can control the disease and eradicate it subsequently from the country, maybe in a decade or so.